Cargando…
Increase in Drug Spending in Canada Due to Extension of Data Protection for Biologics: A Descriptive Study
INTRODUCTION: Biologics are currently protected from competition by eight years of data protection. The renegotiated North American Free Trade Agreement (NAFTA) increases data protection from 8 to 10 years. This study investigates the effect of such an extension on drug spending in Canada. METHODS:...
Autor principal: | Lexchin, Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Longwoods Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008687/ https://www.ncbi.nlm.nih.gov/pubmed/31017862 http://dx.doi.org/10.12927/hcpol.2019.25796 |
Ejemplares similares
-
Health Canada's Proposal to Accelerate New Drug Reviews
por: Lexchin, Joel
Publicado: (2020) -
A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada
por: Morgan, Steven G., et al.
Publicado: (2016) -
Multinational Pharmaceutical Companies Shortchange Canada in Research and Development Investments: Is It Time to Pursue Other Options?
por: Lee, Shoo K., et al.
Publicado: (2023) -
The Pharmaceutical Industry and the Canadian Government: Folie à Deux
por: Lexchin, Joel
Publicado: (2017) -
Enabling Patient Portals to Access Primary Care Medical Records: Maximizing Collaboration in Care between Patients and Providers
por: GorFinkel, Iris, et al.
Publicado: (2019)